Discover open access scientific publications

Search, annotate, share and cite publications

Publications by Alex K. Bryant

Three-Month Posttreatment Prostate-Specific Antigen Level as a Biomarker of Treatment Response in Patients With Intermediate-Risk or High-Risk Prostate Cancer Treated With Androgen Deprivation Therapy and Radiotherapy

Cancer

Cancer Research

Oncology

2018

English

Complement Component 3 Is Associated With Metabolic Comorbidities in Older HIV-Positive Adults

AIDS Research and Human Retroviruses

English

Related publications

Is Neoadjuvant Androgen Deprivation Therapy Necessary for Patients With Intermediate-Risk Prostate Cancer Treated With Proton Therapy?

International Journal of Radiation Oncology Biology Physics

English

Use of Androgen Deprivation Therapy With Radiotherapy for Intermediate- And High-Risk Prostate Cancer Across the United States

English

Concurrent Androgen Deprivation Therapy During Salvage Prostate Radiotherapy Improves Treatment Outcomes in High-Risk Patients

International Journal of Radiation Oncology Biology Physics

English

The Need for Androgen Deprivation Therapy in Patients With Intermediate-Risk Prostate Cancer Treated With Dose-Escalated External Beam Radiation Therapy

International Journal of Radiation Oncology Biology Physics

English

The Effect of Androgen Deprivation Therapy on Prostate Cancer-Specific Mortality in Patients With High-Risk Prostate Cancer Treated With I-125 Brachytherapy as the Sole Radiation Therapeutic Modality

International Journal of Radiation Oncology Biology Physics

English

Intermediate Risk Prostate Cancer Patients Treated With Image Guided Hypofractionated Radiation Therapy

International Journal of Radiation Oncology Biology Physics

English

Risk of Ischemic Stroke in Patients With Prostate Cancer Receiving Androgen Deprivation Therapy in Taiwan

English

Androgen Deprivation Therapy for Prostate Cancer and Risk of Dementia

BJU International

Urology

2019

English

Combined Brachytherapy and External Beam Radiotherapy Without Adjuvant Androgen Deprivation Therapy for High-Risk Prostate Cancer

English

Amanote Research

Discover open access scientific publications

Search, annotate, share and cite publications

Publications by Alex K. Bryant

Three-Month Posttreatment Prostate-Specific Antigen Level as a Biomarker of Treatment Response in Patients With Intermediate-Risk or High-Risk Prostate Cancer Treated With Androgen Deprivation Therapy and Radiotherapy

Complement Component 3 Is Associated With Metabolic Comorbidities in Older HIV-Positive Adults

Related publications

Is Neoadjuvant Androgen Deprivation Therapy Necessary for Patients With Intermediate-Risk Prostate Cancer Treated With Proton Therapy?

Use of Androgen Deprivation Therapy With Radiotherapy for Intermediate- And High-Risk Prostate Cancer Across the United States

Concurrent Androgen Deprivation Therapy During Salvage Prostate Radiotherapy Improves Treatment Outcomes in High-Risk Patients

The Need for Androgen Deprivation Therapy in Patients With Intermediate-Risk Prostate Cancer Treated With Dose-Escalated External Beam Radiation Therapy

The Effect of Androgen Deprivation Therapy on Prostate Cancer-Specific Mortality in Patients With High-Risk Prostate Cancer Treated With I-125 Brachytherapy as the Sole Radiation Therapeutic Modality

Intermediate Risk Prostate Cancer Patients Treated With Image Guided Hypofractionated Radiation Therapy

Risk of Ischemic Stroke in Patients With Prostate Cancer Receiving Androgen Deprivation Therapy in Taiwan

Androgen Deprivation Therapy for Prostate Cancer and Risk of Dementia

Combined Brachytherapy and External Beam Radiotherapy Without Adjuvant Androgen Deprivation Therapy for High-Risk Prostate Cancer